COMP <GO>
NVST vs ICUI // ALTMAN Z-SCORE & DEBT/EQUITY
Envista Holdings Corporation (NYSE) VS. ICU Medical Inc. (NASDAQ) • 15-METRIC TALLY: NVST 9
— ICUI 1
■ METRIC PARITY
LAST: $24.61 (+2.80%) • MKT CAP: $3.95B
balance-sheet
1.61
LAST: $168.65 (+1.36%) • MKT CAP: $4.22B
balance-sheet
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NVST VS. ICUI)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NVST | ICUI | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 54.70% | 36.80% | +17.90 | NVST | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 5.10% | 1.00% | +4.10 | NVST | /roic <GO> |
| EV/EBITDA & P/E Valuation | 16.5x | 46.6x | -30.10 | NVST | /valuation <GO> |
| Free Cash Flow Yield | 5.83% | 2.18% | +3.65 | NVST | /fcf-yield <GO> |
| Operating Margin | 7.90% | 1.90% | +6.00 | NVST | /operating-margins <GO> |
| Net Profit Margin | 1.70% | 0.00% | +1.70 | NVST | /net-margins <GO> |
| Revenue Growth (YoY) | 8.30% | -6.30% | +14.60 | NVST | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 1.61 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 8/9 | +1.00 | NVST | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 56.8 | 50.1 | +6.73 | NVST | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.93 | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 78.2x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.95B | $4.22B | -$264.6M | ICUI | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NVST REV | ICUI REV | NVST GROSS % | ICUI GROSS % | NVST FCF | ICUI FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.72B | $2.23B | 54.7% | 36.8% | $230.4M | $91.8M |
| FY 2024 | $2.51B | $2.38B | 54.7% | 34.6% | $302.7M | $124.7M |
| FY 2023 | $2.57B | $2.26B | — | — | $160.2M | $166.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NVST // BETA 0.93
ICUI // BETA —